Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Hauber

Showing results (51-60 of 165) with videos related to

Pageof 17
Sort By:
Patient Preference and Adherence|July 28, 2011
Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST)A Brett Hauber, Juan Marcos Gonzalez, John Coombs, et al.
Current Medical Research and Opinion|July 14, 2017
Quantifying the relative importance to patients of avoiding symptoms and outcomes of heart failureA Brett Hauber, Engels N Obi, Mark A Price, et al.
Arthritis Research & Therapy|June 1, 2018
Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT studyM Elaine Husni, Anthony Fernandez, Brett Hauber, et al.
Allergy and Asthma Proceedings|May 26, 2009
Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medicationsA Brett Hauber, Ateesha F Mohamed, F Reed Johnson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2022
Assessing Payers' Preferences for Real-World Evidence in the United States: A Discrete Choice ExperimentEnrique M Saldarriaga, Brett Hauber, Josh J Carlson, et al.
Journal of Managed Care Pharmacy : JMCP|September 28, 2010
Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease managementF Reed Johnson, Brett Hauber, Semra Özdemir, et al.
Current Medical Research and Opinion|July 13, 2016
The effect of information on preferences for treatments of metastatic renal cell carcinomaCarol Mansfield, Sandy Srinivas, Connie Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|February 29, 2012
Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysisJohn F P Bridges, Ateesha F Mohamed, Henrik W Finnern, et al.
Cancer Management and Research|May 12, 2017
Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experimentJuan Marcos González, Sarika Ogale, Robert Morlock, et al.
Journal of Opioid Management|October 1, 2011
Economic evaluation of OROS hydromorphone for chronic pain: a Pan-European perspectiveA Brett Hauber, Jochen Fleischmann, Mickael Lothgren, et al.
Pageof 17

Showing results (51-60 of 165) with videos related to

Sort By:
Pageof 17
Patient Preference and Adherence|July 28, 2011
Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST)A Brett Hauber, Juan Marcos Gonzalez, John Coombs, et al.
Current Medical Research and Opinion|July 14, 2017
Quantifying the relative importance to patients of avoiding symptoms and outcomes of heart failureA Brett Hauber, Engels N Obi, Mark A Price, et al.
Arthritis Research & Therapy|June 1, 2018
Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT studyM Elaine Husni, Anthony Fernandez, Brett Hauber, et al.
Allergy and Asthma Proceedings|May 26, 2009
Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medicationsA Brett Hauber, Ateesha F Mohamed, F Reed Johnson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2022
Assessing Payers' Preferences for Real-World Evidence in the United States: A Discrete Choice ExperimentEnrique M Saldarriaga, Brett Hauber, Josh J Carlson, et al.
Journal of Managed Care Pharmacy : JMCP|September 28, 2010
Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease managementF Reed Johnson, Brett Hauber, Semra Özdemir, et al.
Current Medical Research and Opinion|July 13, 2016
The effect of information on preferences for treatments of metastatic renal cell carcinomaCarol Mansfield, Sandy Srinivas, Connie Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|February 29, 2012
Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysisJohn F P Bridges, Ateesha F Mohamed, Henrik W Finnern, et al.
Cancer Management and Research|May 12, 2017
Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experimentJuan Marcos González, Sarika Ogale, Robert Morlock, et al.
Journal of Opioid Management|October 1, 2011
Economic evaluation of OROS hydromorphone for chronic pain: a Pan-European perspectiveA Brett Hauber, Jochen Fleischmann, Mickael Lothgren, et al.
Pageof 17